The disciplines of genetics and genomics — which study the laws of heredity and the structure of the genome — have become central pillars of Roche's research. Both will help us find better medicines and services much faster than ever before. They will contribute considerably to a more efficient and more individualized healthcare delivery.

Genetics and genomics apply new technologies in order to gain valuable knowledge. We are well aware that they gather sensitive information about individuals. That is why Roche's commitment to meeting the highest standards with respect to research — and in particular genetic research — extends beyond national and international regulatory standards. To set these standards, Roche has drawn up a charter on genetics with the help of internationally recognized experts, which lays down the ethical principles for the company's genetic research.

To help us stay the course in what is still largely uncharted territory, Roche has appointed an independent external panel of well-known experts in the fields of genetics, ethics, law, and sociology, plus members of the lay community, as our Science and Ethics Advisory Group. This group has been mandated to provide guidance, advice, and counsel on issues broadly related to genetics.